NICU Antibiotics and Outcomes (NANO) Follow-up Study (NCT05977400)
NICU Antibiotics and Outcomes Follow-Up Study
🩺 Plain-English Summary (8th-Grade Level)
The NANO follow-up study is designed to determine whether a simple, cost-effective intervention- withholding antibiotics at birth- reduces clinically relevant outcomes such as behavioral and neurological impairment at 2 years of age. This study will be the largest study evaluating the effects of early antibiotics in children with comprehensive measures of neurodevelopment linked to genomic variants and microbiota interactions.
Who can join: Review the eligibility criteria below.
Location: Sharp Mary Birch Hospital for Women & Newborns — San Diego, California
Age range: 23 Weeks to 30 Weeks
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (15 Sites)
- Sharp Mary Birch Hospital for Women & Newborns — San Diego, California
- Yale University — New Haven, Connecticut
- University of South Florida — Tampa, Florida
- University of Louisville — Louisville, Kentucky
- State University of New York Downstate — Brooklyn, New York
- Columbia University — New York, New York
- University of Rochester — Rochester, New York
- Westchester Medical Center — Valhalla, New York
- The Pennsylvania State University — Hershey, Pennsylvania
- The Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
- Jefferson Medical College of Thomas Jefferson University — Philadelphia, Pennsylvania
- Magee-Womens Hospital — Pittsburgh, Pennsylvania
- The University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
- University of Texas Health Science Center at San Antonio — San Antonio, Texas
- Sinai Health System — Toronto,
📞 Contact the Study Coordinator
Phone: (858) 939-4170
Email: anup.katheria@sharp.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Premature Birth
- Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation — Halifax,
- Local Version of the Multi-center PREVENT Study Evaluating Cardio-respiratory Instability in Premature Infants — Chicago, Illinois
- Wireless MicroPremVitals Button Sensor in the NICU — Montreal, Quebec
- Growing Little PEAPODS Study — Madison, Wisconsin
- A Randomized Control Trial of a Responsive Parenting Intervention to Support Healthy Brain Development and Self-regulation in Toddlers Born Preterm — Houston, Texas
Explore by condition: All Premature Birth clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.